About this trial
This study collects data from patients undergoing minimally invasive, image-guided cancer treatments at participating hospitals in the Netherlands and France. All treatments are performed as standard clinical care and include procedures such as tumor ablation and catheter-based treatments of cancer in the liver, kidney, lung, and bone.
During these procedures, a spectral angio-CT system is used for image guidance. This advanced CT scanner automatically captures additional imaging information beyond what is used in routine clinical decision-making. The goal of this study is to investigate how this additional imaging information is associated with treatment outcomes, and how it can be used in the future to improve treatment planning, procedural guidance, and prediction of treatment results.
No experimental interventions are performed. Participation does not alter the treatment or follow-up patients receive. Data are collected from medical records and imaging systems and stored securely for analysis.
Eligibility criteria
Qualifiers
Age ≥ 18 years;
Undergoing a clinically indicated IO procedure with a percutaneous or transarterial approach for solid tumors;
Use of spectral angio-CT image guidance as part of standard care;
Written confirmed consent.
Disqualifiers
Patients who are declared incapacitated;
Patients suffering from psychic disorders that make a comprehensive judgement impossible.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Mark C Burgmans, MD PhD
Lead sponsor
Leiden University Medical Center
Sponsor institution
European Commission
Collaborator
Philips Medical Systems
Collaborator
Philips Electronics Nederland BV
Collaborator
Philips France Commercial
Collaborator
Philips GmbH Innovate Technologies
Collaborator
Quantum Surgical
Collaborator
IGEA
Collaborator
Hospices Civils de Lyon
Collaborator
Assistance Publique - Hôpitaux de Paris
Collaborator
EIBIR - European Institute for biomedical imaging research
Collaborator
Cardiovascular and Interventional Radiological Society of Europe
Collaborator
Klinikum der Universität zu Köln, Institut für Klinische Chemie
Collaborator